Evaluating the strength of genetic results: Risks and responsibilities


Autoři: Gregory S. Barsh aff001;  Gregory M. Cooper aff001;  Gregory P. Copenhaver aff003;  Giorgio Sirugo aff004;  Hua Tang aff002;  Scott M. Williams aff005
Působiště autorů: HudsonAlpha Institute for Biotechnology, Huntsville, Alabama, United States of America aff001;  Department of Genetics, Stanford University School of Medicine, Stanford, California, United States of America aff002;  Department of Biology and the Integrative Program for Biological and Genome Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America aff003;  Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America aff004;  Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America aff005
Vyšlo v časopise: Evaluating the strength of genetic results: Risks and responsibilities. PLoS Genet 15(10): e1008437. doi:10.1371/journal.pgen.1008437
Kategorie: Editorial
prolekare.web.journal.doi_sk: 10.1371/journal.pgen.1008437


Zdroje

1. The PLOS Genetics Editors (2019) Expression of Concern: Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease. PLoS Genet 15(10): e1008436. doi: 10.1371/journal.pgen.1008436

2. Vilariño-Güell C, Zimprich A, Martinelli-Boneschi F, Herculano B, Wang Z, Matesanz F, et al. (2019) Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease. PLoS Genet 15(6): e1008180. https://doi.org/10.1371/journal.pgen.1008180 31170158

3. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster,et al. (2015) Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics In Medicine 17(5):405–24. doi: 10.1038/gim.2015.30 25741868

4. Barsh G. S., Copenhaver G. P., Gibson G., & Williams S. M. (2012). Guidelines for genome-wide association studies. PLoS Genet, 8(7), e1002812. doi: 10.1371/journal.pgen.1002812 22792080

5. MacArthur D. G., Manolio T. A., Dimmock D. P., Rehm H. L., Shendure J., Abecasis G. R. et al. (2014). Guidelines for investigating causality of sequence variants in human disease. Nature, 508(7497), 469–476. doi: 10.1038/nature13127 24759409

6. Williams SM, Haines JL. (2011). Correcting away the hidden heritability. Ann Hum Genet, 75(3), 348–350. doi: 10.1111/j.1469-1809.2011.00640.x 21488852

7. He Z., Xu B., Buxbaum J., & Ionita-Laza I. (2019). A genome-wide scan statistic framework for whole-genome sequence data analysis. Nat Commun, 10(1), 3018. doi: 10.1038/s41467-019-11023-0 31289270

8. Werling D. M., Brand H., An J. Y., Stone M. R., Zhu L., Glessner J. T. et al. (2018). An analytical framework for whole-genome sequence association studies and its implications for autism spectrum disorder. Nat Genet, 50(5), 727–736. doi: 10.1038/s41588-018-0107-y 29700473

9. Tilghman J. M., Ling A. Y., Turner T. N., Sosa M. X., Krumm N., Chatterjee S. et al. (2019). Molecular Genetic Anatomy and Risk Profile of Hirschsprung’s Disease. N Engl J Med, 380(15), 1421–1432. doi: 10.1056/NEJMoa1706594 30970187

10. Li A. H., Hanchard N. A., Furthner D., Fernbach S., Azamian M., Nicosia A. et al. (2017). Whole exome sequencing in 342 congenital cardiac left sided lesion cases reveals extensive genetic heterogeneity and complex inheritance patterns. Genome Med, 9(1), 95. doi: 10.1186/s13073-017-0482-5 29089047

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2019 Číslo 10

Najčítanejšie v tomto čísle

Tejto téme sa ďalej venujú…


Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Faktory ovlivňující léčbu levotyroxinem
nový kurz

Kurz originály vs. generika

Autori: MUDr. Petr Výborný, CSc., FEBO

Autori: MUDr. Jiří Horažďovský, Ph.D

Klinická farmakokinetika betablokátorů

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa